Literature DB >> 1158039

Serum proinsulin in children and adolescents with chemical diabetes.

A L Rosenbloom, J I Starr, D Juhn, A H Rubenstein.   

Abstract

Proinsulin levels (PLC) in serum were determined after gel filtration on specimens obtained during oral glucose tolerance testing (OGTT) in seven patients with repeated abnormality in OGTT and in a group of seven control subjects matched for age. Fasting and thirty-, sixty-, and 120-minute postglucose venous samples were analyzed for glucose (PG) and immunocreactive insulin (IRI) as well as PLC, PG and IRI mean concentrations were greater at all testing times in the patient population, but the mean IRI/PG was significantly higher in the patients only at fasting. PLC mean levels were higher in the patients but not to a level of significance. Percentage of total IRI atributable to PLC at each time point was identical between the two groups. The apparcent diminished effectiveness of circulating insulin in chemical diabetes cannot be attributed to an abnormal proportion of proinsulin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1158039     DOI: 10.2337/diab.24.8.753

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Indirect two-site immunoradiometric assay of rat and mouse proinsulin.

Authors:  D K Yue; O M Gibby; S D Luzio; N Yanaihara; C N Hales
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

2.  Specific and direct radioimmunoassay for human proinsulin in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

3.  Serum proinsulin in normal and gestational diabetic pregnancy.

Authors:  C Kühl
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

4.  Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism.

Authors:  M Kobayashi; J M Olefsky; J Elders; M E Mako; B D Given; H K Schedwie; R H Fiser; R L Hintz; J A Horner; A H Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.